Skip to main content
. 2015 Apr 13;2015(4):CD008457. doi: 10.1002/14651858.CD008457.pub2

Summary of findings 2. Summary of findings ‐ chlorhexidine gel.

Chlorhexidine gel compared with no treatment for prevention of caries in children and adolescents
Patient or population: children and adolescents
Settings: all
Intervention: chlorhexidine gel
Comparison: no treatment
Outcomes Illustrative comparative risks* (95% CI) Relative effect
 (95% CI) No of Participants
 (studies) Quality of the evidence
 (GRADE) Comments
Assumed risk Corresponding risk
No treatment Chlorhexidine
Presence of new caries in the primary teeth (24‐months follow‐up) 16 per 10001 16 per 1000
(6 to 45)
RR 1.00 (0.36 to 2.77) 487 (2) ⊕⊝⊝⊝2very low Chlorhexidine concentration 0.12% gel
70 per 1000 70 per 1000
(25 to 194)
Mutans streptococci prevalence
(24‐months follow‐up)
180 per 10003 227
(171 to 299
RR 1.26 (0.95 to 1.66) 490 (2) ⊕⊝⊝⊝4very low Chlorhexidine concentration 0.12% gel
466 per 10003 587 per 1000 
 (443 to 774)
Adverse events (24‐months follow‐up)           Both studies reported there were no adverse events
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
 CI: confidence interval; DMFS: decayed, missing and filled surfaces; RR: risk ratio
GRADE Working Group grades of evidence
 High quality: Further research is very unlikely to change our confidence in the estimate of effect.
 Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
 Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
 Very low quality: We are very uncertain about the estimate.

1. Two trials assessed this outcome; the reported risk of caries in the control group was 1.6% and 6.9%.

2. We downgraded the quality of the evidence due to risk of bias (we assessed both studies to be at high risk of bias overall), imprecision of the estimate due to low numbers of events in both the control and intervention groups, and indirectness (infants administered very low daily concentration).

3. Two trials assessed this outcome; the reported risk of mutans streptococci in the control group was 46.6% and 18.1%.

4. We downgraded the quality of the evidence due to risk of bias (we assessed both studies to be at high risk of bias overall), imprecision, and indirectness.